These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 12063545)
1. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. Djonov V; Cresto N; Aebersold DM; Burri PH; Altermatt HJ; Hristic M; Berclaz G; Ziemiecki A; Andres AC Int J Oncol; 2002 Jul; 21(1):25-30. PubMed ID: 12063545 [TBL] [Abstract][Full Text] [Related]
2. Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer. Sivula A; Talvensaari-Mattila A; Lundin J; Joensuu H; Haglund C; Ristimäki A; Turpeenniemi-Hujanen T Breast Cancer Res Treat; 2005 Feb; 89(3):215-20. PubMed ID: 15754118 [TBL] [Abstract][Full Text] [Related]
3. Low serum level of pro-matrix metalloproteinase 2 correlates with aggressive behavior in breast carcinoma. Kuvaja P; Talvensaari-Mattila A; Pääkkö P; Turpeenniemi-Hujanen T Hum Pathol; 2006 Oct; 37(10):1316-23. PubMed ID: 16949931 [TBL] [Abstract][Full Text] [Related]
4. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740 [TBL] [Abstract][Full Text] [Related]
5. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977 [TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer. Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670 [TBL] [Abstract][Full Text] [Related]
8. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Jang KS; Han HX; Paik SS; Brown PH; Kong G Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432 [TBL] [Abstract][Full Text] [Related]
9. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. Kim SH; Cho NH; Kim K; Lee JS; Koo BS; Kim JH; Chang JH; Choi EC J Surg Oncol; 2006 Mar; 93(4):330-7. PubMed ID: 16496371 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression. Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110 [TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820 [TBL] [Abstract][Full Text] [Related]
12. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Vartanian RK; Weidner N Am J Pathol; 1994 Jun; 144(6):1188-94. PubMed ID: 7515558 [TBL] [Abstract][Full Text] [Related]
13. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015 [TBL] [Abstract][Full Text] [Related]
14. COX-2 expression does not correlate with microvessel density in breast cancer. Thorat MA; Mehrotra S; Morimiya A; Badve S Pathobiology; 2009; 76(1):39-44. PubMed ID: 19188749 [TBL] [Abstract][Full Text] [Related]
15. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Quaranta M; Daniele A; Coviello M; Venneri MT; Abbate I; Caringella ME; Di Tardo S; Divella R; Trerotoli P; Di Gennaro M; Schittulli F; Fransvea E; Giannelli G Anticancer Res; 2007; 27(5B):3593-600. PubMed ID: 17972522 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts. Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194 [TBL] [Abstract][Full Text] [Related]
18. [Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis]. Wang L; Zhang LH; Li YL; Li YL; Liu Z Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):782-6. PubMed ID: 12899759 [TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas. Zhang YG; DU J; Tian XX; Zhong YF; Fang WG Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy. Rahko E; Jukkola A; Melkko J; Paavo P; Bloigu R; Talvensaari-Mattila A; Turpeenniemi-Hujanen T Anticancer Res; 2004; 24(6):4247-53. PubMed ID: 15736480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]